Literature DB >> 20048008

Holy fire in an HIV-positive man: a case of 21st-century ergotism.

Georg Fröhlich1, Vladimir Kaplan, Beatrice Amann-Vesti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20048008      PMCID： PMC2831703          DOI： 10.1503/cmaj.091362

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Risk of stroke, gangrene from ergot drug interactions.

Authors:  Eric Wooltorton
Journal:  CMAJ       Date:  2003-04-15       Impact factor: 8.262

2.  Sodium nitroprusside treatment of ergotamine-induced peripheral ischemia.

Authors:  N Carliner; D P Denune; C S Finch; L I Goldberg
Journal:  JAMA       Date:  1974-01-21       Impact factor: 56.272

3.  Reversal of ergotamine-induced arteriospasm by mechanical intra-arterial dilatation.

Authors:  E Shifrin; A Perel; D Olschwang; Y Diamant; S Cotev
Journal:  Lancet       Date:  1980-12-13       Impact factor: 79.321

4.  Clinical ergotism induced by ritonavir.

Authors:  A Vila; A Mykietiuk; P Bonvehì; E Temporiti; A Urueña; F Herrera
Journal:  Scand J Infect Dis       Date:  2001

5.  Chronic ergot toxicity presenting with bilateral external iliac artery dissection and lower extremity rest pain.

Authors:  Afshin M Molkara; Ahmed M Abou-Zamzam; Theodore H Teruya; Christian Bianchi; J David Killeen
Journal:  Ann Vasc Surg       Date:  2006-11       Impact factor: 1.466

6.  Brachial artery stenosis secondary to ergotism and responsive to nifedipine.

Authors:  A A Borges; C C Lin; G J Jabaji; W L Thomas
Journal:  Postgrad Med       Date:  1986-08       Impact factor: 3.840

7.  History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.

Authors:  P C Tfelt-Hansen; P J Koehler
Journal:  Cephalalgia       Date:  2008-05-05       Impact factor: 6.292

8.  Successful treatment of ergotism with Iloprost--a case report.

Authors:  R Piquemal; J Emmerich; J L Guilmot; J N Fiessinger
Journal:  Angiology       Date:  1998-06       Impact factor: 3.619
  8 in total
  3 in total

Review 1.  Pharmacokinetics and pharmacodynamics of cytochrome P450 inhibitors for HIV treatment.

Authors:  Yuqing Gong; Sanjana Haque; Pallabita Chowdhury; Theodore J Cory; Sunitha Kodidela; Murali M Yallapu; John M Norwood; Santosh Kumar
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-04-20       Impact factor: 4.481

2.  Ergotism in Thailand caused by increased access to antiretroviral drugs: a global warning.

Authors:  Anchalee Avihingsanon; Reshmie A Ramautarsing; Gompol Suwanpimolkul; Ploenchan Chetchotisakd; Chureeratana Bowonwatanuwong; Supunnee Jirajariyavej; Patcharee Kantipong; Hutsaya Tantipong; June Pirapon Ohata; Chusana Suankratay; Kiat Ruxrungtham; David M Burger
Journal:  Top Antivir Med       Date:  2014-01

Review 3.  Cabergoline: a review of its use in the inhibition of lactation for women living with HIV.

Authors:  Karen J Tulloch; Philippe Dodin; Fannie Tremblay-Racine; Chelsea Elwood; Deborah Money; Isabelle Boucoiran
Journal:  J Int AIDS Soc       Date:  2019-06       Impact factor: 5.396
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.